Etanercept and the treatment of multicentric reticulohistiocytosis

Arch Dermatol. 2005 Sep;141(9):1167-8. doi: 10.1001/archderm.141.9.1167-b.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Etanercept
  • Histiocytosis, Non-Langerhans-Cell / drug therapy*
  • Histiocytosis, Non-Langerhans-Cell / pathology
  • Humans
  • Immunoglobulin G / administration & dosage*
  • Injections, Subcutaneous
  • Male
  • Receptors, Tumor Necrosis Factor / administration & dosage*
  • Treatment Failure

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept